A special audio program developed from a live webinar produced in conjunction with the 2020 AACR Virtual Annual Meeting. Featuring perspectives from Drs Maha Hussain, Ursula Matulonis, Philip A Philip and Hope S Rugo.

Gynecologic Oncology Update

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers

Featuring a discussion on the current and future role of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers with Dr David O’Malley, moderated by Neil Love, MD.

Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers 2020

A special audio program from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Mansoor Raza Mirza, Kathleen Moore and Shannon N Westin.

The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer

A special audio program developed from the tenth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Dr Emmanuel S Antonarakis, Ms Gretchen Santos Fulgencio, Dr Kathleen Moore, Dr Joyce O’Shaughnessy, Dr Michael J Pishvaian and Ms Deborah Wright.

Oncology Grand Rounds Series: Part 10 — PARP Inhibition in the Management of Common Cancers

A special audio program developed from the fifth in a series of 11 integrated webinars held in association with the 2020 ONS Annual Congress. Featuring perspectives from Ms Paula J Anastasia, Ms Jennifer Filipi, Dr David M O’Malley and Dr Shannon N Westin.

Oncology Grand Rounds Series: Part 5 — Gynecologic Cancers

A special audio supplement to a developed from an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Michael J Birrer, Ursula Matulonis, David M O’Malley and Krishnansu S Tewari.

Gyn Onc 2020 Novel Therapies Interviews | Highlights from a discussion with Michael J Birrer, MD, PhD, Ursula Matulonis, MD, David M O’Malley, MD and Krishnansu S Tewari, MD

A special audio supplement to an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Robert L Coleman, Stephanie Lheureux, Joyce F Liu and Kathleen Moore.

Gyn Onc 2020 PARP Interviews | Highlights from a discussion with Robert L Coleman, MD, Stephanie Lheureux, MD, PhD, Joyce F Liu, MD, MPH and Kathleen Moore, MD

A special audio program developed from an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Michael J Birrer, Ursula Matulonis, David M O’Malley and Krishnansu S Tewari.

Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers

A special audio program developed from an independent satellite symposium during the Society of Gynecologic Oncology’s 2020 Annual Meeting on Women’s Cancer Webinar Series. Featuring perspectives from Drs Robert L Coleman, Stephanie Lheureux, Joyce F Liu and Kathleen Moore.

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer

Investigator Perspectives on the Current and Future Management of Newly Diagnosed Ovarian Cancer. Featuring an interview with Bradley J Monk, MD conducted by Neil Love, MD. Produced by Research To Practice.

Ovarian Cancer Investigators 2019 | Interview with Bradley J Monk, MD

Investigator Perspectives on the Current and Future Management of Newly Diagnosed Ovarian Cancer. Featuring an interview with Professor Jonathan A Ledermann conducted by Neil Love, MD. Produced by Research To Practice.

Ovarian Cancer Investigators 2019 | Interview with Professor Jonathan A Ledermann

Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer. Featuring an interview with Kathleen Moore, MD conducted by Neil Love, MD. Produced by Research To Practice.

Gyn Onc 2019 – PARP Interview

Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer. An Independent CME Satellite Symposium During the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. Featuring Robert L Coleman, MD, Professor Jonathan A Ledermann, Stephanie Lheureux, MD, PhD and Kathleen Moore, MD. Moderated by Neil Love, MD. Produced by Research To Practice.

Gyn Onc 2019 – PARP

Data + Perspectives: Clinical Investigators Explore Emerging Research and Actual Patients with Uterine Sarcomas. An Independent CME Satellite Symposium During the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. Featuring Amanda Nickles Fader, MD, Mario M Leitao Jr, MD, Angeles Alvarez Secord, MD, MHSc and Brian A Van Tine, MD, PhD. Moderated by Neil Love, MD. Produced by Research To Practice.

Gyn Onc 2019 – Sarcoma

PARP Inhibition in Four Common Cancers: Biology, Clinical Research Database and Therapeutic Strategy. Featuring Emmanuel S Antonarakis, MD, Kathleen Moore, MD, Michael J Pishvaian, MD, PhD and Melinda Telli, MD. Moderated by Neil Love, MD. Produced by Research To Practice.

AACR PARP 2019

Featuring one-on-one discussions with leading clinical investigators, this series bridges the gap between research and patient care by providing practicing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.

hubhopper

Gynecologic Oncology Update

hubhopper